Mooi WJ - Search Results

1

Ipenburg NA, Mooi WJ, van Doorn R. Ipenburg NA, et al. Among authors: mooi wj. Ned Tijdschr Geneeskd. 2017;161:D1687. Ned Tijdschr Geneeskd. 2017. PMID: 29219794 Dutch.

2

Incidence and relative survival of melanoma in children and adolescents in the Netherlands, 1989-2013.

Eggen CAM, Durgaram VVL, van Doorn R, Mooi WJ, Pardo LM, Pasmans SGMA, Hollestein LM. Eggen CAM, et al. Among authors: mooi wj. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):956-961. doi: 10.1111/jdv.14665. Epub 2017 Nov 28. J Eur Acad Dermatol Venereol. 2018. PMID: 29080310

3

[Melanocytic tumour of uncertain malignant potential; practical dilemmas].

Rozendaal AM, de Haas ERM, Mooi W, de Roos KP. Rozendaal AM, et al. Ned Tijdschr Geneeskd. 2019 Jul 5;163:D3659. Ned Tijdschr Geneeskd. 2019. PMID: 31283126 Dutch.

4

[Three patients with a Spitz naevus that later turned out to be a melanoma].

Bron JL, Jaspars EH, Molenkamp BG, Meijer S, Mooi WJ, van Leeuwen PA. Bron JL, et al. Among authors: mooi wj. Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1852-8. Ned Tijdschr Geneeskd. 2005. PMID: 16128184 Dutch.

5

[Should congenital melanocytic nevi be removed?].

de Bliek JP, Neering H, Mooi WJ. de Bliek JP, et al. Among authors: mooi wj. Ned Tijdschr Geneeskd. 1990 Oct 20;134(42):2029-31. Ned Tijdschr Geneeskd. 1990. PMID: 2234173 Review. Dutch. No abstract available.

6

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.

Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS. Kuilman T, et al. Among authors: mooi wj. Cell. 2008 Jun 13;133(6):1019-31. doi: 10.1016/j.cell.2008.03.039. Cell. 2008. PMID: 18555778 Free article.

7

[Improved compliance with the 'Melanoma' treatment guideline].

Veerbeek L, van de Poll-Franse LV, Bekkenk MW, Bergman W, Hoekstra HJ, Jansen-Landheer ML, Kruit WH, Mooi WJ, de Vries E, van der Rhee HJ. Veerbeek L, et al. Among authors: mooi wj. Ned Tijdschr Geneeskd. 2010;154:A858. Ned Tijdschr Geneeskd. 2010. PMID: 20170570 Dutch.

8

Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.

van der Rhee JI, de Snoo FA, Vasen HFA, Mooi WJ, Putter H, Gruis NA, Kukutsch NA, Bergman W. van der Rhee JI, et al. Among authors: mooi wj. J Am Acad Dermatol. 2011 Aug;65(2):289-296. doi: 10.1016/j.jaad.2010.06.067. Epub 2011 May 12. J Am Acad Dermatol. 2011. PMID: 21570154 Free PMC article.

9

[Revision of the national guideline 'Melanoma'].

Veerbeek L, Kruit WH, de Wilt J, Mooi WJ, Bergman W; Multidisciplinaire Richtlijnwerkgroep Melanoom. Veerbeek L, et al. Among authors: mooi wj. Ned Tijdschr Geneeskd. 2013;157(12):A6136. Ned Tijdschr Geneeskd. 2013. PMID: 23515047 Dutch.

10

Surveillance of second-degree relatives from melanoma families with a CDKN2A germline mutation.

van der Rhee JI, Boonk SE, Putter H, Cannegieter SC, Flinterman LE, Hes FJ, de Snoo FA, Mooi WJ, Gruis NA, Vasen HF, Kukutsch NA, Bergman W. van der Rhee JI, et al. Among authors: mooi wj. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1771-7. doi: 10.1158/1055-9965.EPI-13-0130. Epub 2013 Jul 29. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23897584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page